Aquestive Therapeutics, Inc. AQST Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s software and technology licenses, net?
- Aquestive Therapeutics, Inc. (AQST) reported software and technology licenses, net of $2.64M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Aquestive Therapeutics, Inc.'s software and technology licenses, net decreased by 37.5% year-over-year, from $4.22M to $2.64M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s software and technology licenses, net has grown at a -19.5% compound annual growth rate (CAGR), from $7.84M to $2.64M.